EAM
CALA

EverPoint Asset Management’s Calithera Biosciences, Inc CALA Stock Holding History

EverPoint Asset Management’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-10,186
Closed -$3.35M – 626
2015
Q1 		$3.35M Buy
+10,186
New +$3.62M 0.06% 352

Other funds holding CALA

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EverPoint Asset Management's CALA Position: Q2 2015 in Review

EverPoint Asset Management sold out of Calithera Biosciences, Inc (CALA) in Q2 2015, closing a stake of 10,186 shares — an estimated $3.35M sold.

EverPoint Asset Management first reported a position in CALA in Q1 2015 and held it in 1 quarter. The position peaked at $3.35M in Q1 2015. 52 funds tracked by Wall St. Rank hold CALA as of Q2 2015.

  • EverPoint Asset Management reported no remaining Calithera Biosciences, Inc position as of Q2 2015 after selling out during the quarter.
  • EverPoint Asset Management sold 10,186 Calithera Biosciences, Inc shares in Q2 2015, an estimated $3.35M.
  • EverPoint Asset Management first reported a position in Calithera Biosciences, Inc in Q1 2015 and held it in 1 quarter.
  • EverPoint Asset Management's Calithera Biosciences, Inc position peaked at $3.35M in Q1 2015.
  • 52 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2015.

Based on EverPoint Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.